The USPSTF recommends providing interventions through pregnancy and just after start to support breastfeeding. with next-line medicines used in the shorter MDR-TB regimen or in whom resistance to fluoroquinolones and second-line injectable agents has long been excluded, a shorter MDR-TB regimen of 9??12?�months could be utilized in lieu of the ex… Read More